Status:
COMPLETED
Evolution of Cardiopulmonary Fitness in Children With Congenital Heart Disease
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
6-18 years
Brief Summary
With an incidence of 0.8 %, congenital heart disease (CHD) is the leading cause of congenital anomalies at birth. Medical advances in CHD have transferred the mortality from childhood to adulthood and...
Detailed Description
Longitudinal multi-center study from November 2010 to September 2020 in two pediatric CPET laboratories (center 1: M3C Regional Pediatric and Congenital Cardiology Centre, Montpellier University Hospi...
Eligibility Criteria
Inclusion
- Inclusion criteria for CHD group :
- \- children with CHD included in the first study carried out from 2010 to 2015 6 and who have had at least 1 CPET 1 year after the first.
- Inclusion criteria for control group :
- children referred for a nonsevere functional symptom linked to exercise (murmur, palpitation or dyspnoea) or for a medical sports certificate.
- completely normal check-up, including physical examination, ECG, echocardiography and spirometry.
- Exclusion criteria for control group:
- Children with any chronic disease, medical condition (cardiac, neurological, respiratory, muscular or renal)
- Children with any medical treatment
- Children requiring any further specialised medical consultation
Exclusion
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04815577
Start Date
March 1 2020
End Date
February 20 2021
Last Update
October 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34295